⇚ Regimen POMALYST® w/DECADRON® - for Myeloma Medical Name POMALYST® (Pomalidomide) with DECADRON® (Dexamethasone) for Myeloma Cycles Given N/A Delivery Phases N/A Special Instructions The dose of DECADRON® may be reduced to 20mg per day for patients greater than 75 years of age. Monitor blood sugars. Consider prophylactic anti-thrombotic measures as there may be a risk for DVT and pulmonary embolism. Treatment is given until disease progression. References Dimopoulos MA, et al. ASH Meeting, 2012 - VIEW External References http://ash.confex.com/ash/2012/webprogram/Paper55448.html - VIEW Drug Mode Given Standard Dose Days to Be Given Frequency Solution Volume Duration POMALYST® (Pomalidomide) PO 4 mg D1 thru D21 q28 N/A N/A N/A DECADRON® (Dexamethasone) PO 40 mg D1,8,15 and 22 q28 N/A N/A N/A